Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Tai

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Frontiers in Neurology|March 22, 2021
Association Between Low-Density Lipoprotein Cholesterol and Platelet Distribution Width in Acute Ischemic StrokeJian Yuan, Jian Cai, Pei Zhao, et al.
CNS Neuroscience & Therapeutics|July 16, 2015
Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel ResponseYan Han, Hui-Hui Lv, Xu Liu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 2, 2015
Comparison of VerifyNow P2Y12 and thrombelastography for assessing clopidogrel response in stroke patients in ChinaHui-Hui Lv, Shuai Wu, Xu Liu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2016
Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in ratsJin-Hang Gao, Shi-Lei Wen, Huan Tong, et al.
The Journal of Clinical Investigation|March 17, 2026
Epigenetically controlled endothelial promyelocytic leukemia drives liver inflammation and fibrosisCan Gan, Enjiang Lai, Yang Tai, et al.
Frontiers in Neurology|May 13, 2022
Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical TrialXiao-Ying Yao, Li Xie, Yu Cai, et al.
Cell Death and Differentiation|March 18, 2026
Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trialXiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Frontiers in Neurology|March 22, 2021
Association Between Low-Density Lipoprotein Cholesterol and Platelet Distribution Width in Acute Ischemic StrokeJian Yuan, Jian Cai, Pei Zhao, et al.
CNS Neuroscience & Therapeutics|July 16, 2015
Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel ResponseYan Han, Hui-Hui Lv, Xu Liu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 2, 2015
Comparison of VerifyNow P2Y12 and thrombelastography for assessing clopidogrel response in stroke patients in ChinaHui-Hui Lv, Shuai Wu, Xu Liu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2016
Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in ratsJin-Hang Gao, Shi-Lei Wen, Huan Tong, et al.
The Journal of Clinical Investigation|March 17, 2026
Epigenetically controlled endothelial promyelocytic leukemia drives liver inflammation and fibrosisCan Gan, Enjiang Lai, Yang Tai, et al.
Frontiers in Neurology|May 13, 2022
Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical TrialXiao-Ying Yao, Li Xie, Yu Cai, et al.
Cell Death and Differentiation|March 18, 2026
Human umbilical cord mesenchymal stromal cells therapy for neuromyelitis optica spectrum disorder: a phase 1/2a trialXiao-Ying Yao, Zhong-Jiao Lu, Nan Zhao, et al.
Pageof 9